Another day, another win for womankind.
On June 21, the U.S. Food and Drug Administration (FDA) approved a new drug that'll help boost your sex drive 'cause honey, your needs matter, too. Called Vyleesi, the drug is meant to "treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women."
In a statement, Hylton V. Joffe, the director of the Center for Drug Evaluation and Research’s Division of Bone, Reproductive and Urologic Products, said, "There are women who, for no known reason, have reduced sexual desire that causes marked distress, and who can benefit from safe and effective pharmacologic treatment."
To be clear, HSDD isn't due to any co-existing condition, relationship problems, or side effects of medication. Unfortunately, it can develop randomly even if you've never had problems with your sex drive before.
Unlike the first female libido drug Addyi, which is a once-a-day pill, Vyleesi is administered through a shot: "Patients inject Vyleesi under the skin of the abdomen or thigh at least 45 minutes before anticipated sexual activity and may decide the optimal time to use Vyleesi based on how they experience the duration of benefit and any side effects, such as nausea. Patients should not use more than one dose within 24 hours or more than eight doses per month." Vyleesi triggers receptors for melanocortin, a brain-stimulating hormone associated with sexual arousal and appetite.
Before it was approved, Vyleesi went through two 24-week randomized, double-blind, placebo-controlled trials. The study involved 1,247 premenopausal women with acquired, generalized HSDD. The most common side effects include: headaches, nausea with vomiting, flushing, and reactions around the areas where the drug was injected. In one percent of the participants, there was "darkening of the gums and parts of the skin, including the face and breasts, which did not go away in about half the patients after stopping treatment."
Would you be willing to try Vyleesi?
Follow Ysa on Instagram.